Primary Care Reports – December 1, 2003

December 1, 2003

• Allergies and Allergy Therapy — Part I

  The objective of this monograph is to provide an overview of the scope of allergic disorders, and review the current understanding of the mechanism of the allergic response. Due to the extensive nature of the topic, we will limit our discussion to systemic reactions eliciting an IgE-mediated response. Further, the intimate relationship between organs involved will be reviewed, particularly the relationship between allergic rhinitis and asthma. Part I includes the current evaluation, including historical features, exposures, physical exam findings, and ancillary diagnostic options will be reviewed.

  Read more about Allergies and Allergy Therapy — Part I - Primary Care Reports – December 1, 2003

• Pharmacology Watch: Eplerenone Cleared for CHF Patients with Sustained MI

  The FDA has approved Pfizer's eplerenone (Inspra) for the treatment of congestive heart failure (CHF) in patients who have sustained a myocardial infarction.

  Read more about Pharmacology Watch: Eplerenone Cleared for CHF Patients with Sustained MI - Primary Care Reports – December 1, 2003

• Clinical Briefs in Primary Care Supplement

  Read more about Clinical Briefs in Primary Care Supplement - Primary Care Reports – December 1, 2003